Company intelligence / Profile preview

Biotorax

Jundiaí, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

BioTorax is a Brazilian biotechnology company specializing in the development of advanced solutions for thoracic surgery and respiratory health. The company's flagship product, Bio-Sil, is a high-purity, sterile talc used for pleurodesis, a procedure to treat recurrent pleural effusions and pneumothorax. BioTorax focuses on improving patient outcomes through rigorous quality control and innovative delivery systems for thoracic applications. The company originated from academic research at the University of São Paulo and the Jundiaí Medical School, emphasizing clinical validation. BioTorax serves the healthcare market in Latin America, providing specialized tools for pulmonologists and thoracic surgeons.

Therapeutic areas: OncologyPulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Biotorax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotorax.

Explore the full profile